| Financial Year |
March 31 2023 |
| Monetary Funds |
133,532,516.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,517,329.48 |
| Accounts Receivable |
170,034,672.98 |
| Advances to Suppliers |
29,433,254.20 |
| Other Receivables |
12,016,556.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
17,976,606.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,008,863.29 |
| Total Current Assets |
408,299,635.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
622,137,901.23 |
| Under-construction Projects |
27,710,281.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
102,813,535.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,715,647.27 |
| Deferred Income Tax Assets |
8,361,028.99 |
| Other Non-Current Assets |
58,049,946.33 |
| Sub-Total of Non-Current Assets |
823,788,341.19 |
| Total Assets |
1,232,087,977.18 |
| Short-Term Loans |
70,110,250.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
27,000,000.00 |
| Accounts Payable |
95,696,040.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,593,722.30 |
| Taxes Payable |
3,366,863.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,297,179.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,239,565.66 |
| Other Current Liabilities |
2,244,923.22 |
| Sub-Total of Current Liabilities |
228,413,560.59 |
| Long-term Loans |
19,200,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
77,206,412.26 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
124,147,385.06 |
| Total Liabilities |
352,560,945.65 |
| Paid-In Capital(Or Share Stock) |
112,466,134.00 |
| Capital Surplus |
543,242,415.81 |
| Surplus Reserve |
26,939,439.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
185,455,661.25 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
879,527,031.53 |
| Owner's Equity（Stockholder's Equity） |
879,527,031.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,232,087,977.18 |
